Luca Posa Selected Research

Ubiquitin

12/2020

The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Posa Research Topics

Disease

10	Pain (Aches) 12/2023 - 01/2016
8	Neuralgia (Stump Neuralgia) 12/2023 - 01/2018
5	Hyperalgesia 12/2023 - 01/2019
2	Mental Disorders (Mental Disorder) 05/2024 - 01/2018
2	Chronic Pain 12/2023 - 08/2023
1	Drug-Related Side Effects and Adverse Reactions 11/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Fabry Disease (Fabry's Disease) 10/2021
1	Social Phobia 01/2021
1	Autism Spectrum Disorder 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2020
1	Anhedonia 07/2020
1	Mood Disorders (Mood Disorder) 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 11/2016

Drug/Important Bio-Agent (IBA)

4	Analgesics (Analgesic Drugs)IBA 12/2023 - 01/2018
4	MelatoninIBA 11/2022 - 01/2018
3	Opioid Analgesics (Opioids)IBA 12/2023 - 01/2022
3	Serotonin (5 Hydroxytryptamine)IBA 12/2023 - 01/2019
3	mu Opioid Receptors (mu Opioid Receptor)IBA 11/2022 - 01/2016
3	MT2 Melatonin ReceptorIBA 11/2022 - 01/2018
2	Dronabinol (THC)FDA LinkGeneric 12/2023 - 07/2020
2	Morphine (MS Contin)FDA LinkGeneric 12/2023 - 01/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2022 - 12/2020
2	N- (2- ((3- bromophenyl)- (4- fluorophenyl)amino)ethyl)acetamideIBA 11/2022 - 01/2018
2	Hallucinogens (Psychedelics)IBA 01/2021 - 01/2018
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2020 - 05/2019
2	Lysergic Acid Diethylamide (LSD)IBA 01/2018 - 11/2016
1	MT1 Melatonin ReceptorIBA 05/2024
1	delta Opioid Receptors (delta Opioid Receptor)IBA 11/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	GlycosphingolipidsIBA 10/2021
1	GalactosidasesIBA 10/2021
1	EnzymesIBA 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2021
1	ONX 0912IBA 12/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2020
1	Proteasome InhibitorsIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	preproenkephalinIBA 12/2020
1	Antineoplastic Agents (Antineoplastics)IBA 12/2020
1	UbiquitinIBA 12/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2020
1	Sucrose (Saccharose)IBA 07/2020
1	CannabidiolIBA 01/2019
1	5-HT1A Serotonin ReceptorIBA 01/2019
1	Psilocybin (Psilocibin)IBA 01/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	N- (2- ((3- methoxyphenyl)phenylamino)ethyl)acetamideIBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 11/2016
1	Methadone (Dolophine)FDA LinkGeneric 01/2016

Therapy/Procedure

2	Analgesia 01/2022 - 01/2019
1	Therapeutics 01/2016